Search

everythinglearnresearchcommunity

for

Search:↓

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Stat3 activation increases hair follicle progenitors but reduces bulge region stem cells.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Mesenchymal stem cells and their secretions might help treat chronic skin inflammation in atopic dermatitis.

Researchers developed a 3D skin model with its own immune and blood vessel cells to better understand skin health and disease.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Alopecia areata may be linked to atopic diseases like eczema, asthma, and allergies.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Hair loss treatment caused more hair loss in a man.

Stem cell behavior varies with stimuli, and lineage changes can happen without affecting stem cell division.

β‐thymosins, especially thymosin β4, help in heart protection, wound healing, and hair growth by stabilizing actin in cells.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Triamcinolone acetonide therapy for hair loss may cause a skin condition called linear lichen planus.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

The method effectively delivers vaccines through the skin without needles.

Skin bacteria can help wound healing by activating certain immune cells.

Personalized treatment considering atopic status and cytokine profiles may help in managing pediatric alopecia areata.

Noncoding dsRNA boosts hair growth by activating TLR3 and increasing retinoic acid.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Certain proteins and cytokines are key in causing psoriatic skin issues.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

The Fas/FasL pathway may play a role in alopecia areata.

ITK inhibitors may effectively treat alopecia areata.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

PDCD4 is important for controlling skin cell growth and healing.